On the banks of the Nile in Namasagali, where small-holder cassava farmers have long battled with falling prices and ...

Chairman Seo Jeong-jin of Celltrion Group announced plans to simultaneously expand production facilities in the U.S. and ...

Market, valued at USD 8.8 billion in 2023, is set to grow at a compound annual growth rate (CAGR) of 5.93% from 2024 to 2032, reaching an estimated market size of USD 14.8 billion by 2032. Vitamin K3, ...

The plans could be related to $23 billion effort by Swiss pharmaceutical Novartis to expand its manufacturing capabilities in ...

Exxon Mobil closes its Fife ethylene plant due to costs, highlighting the severe challenges and capacity decline in Europe's ...

Now, more than half a year later, the expansion plan for one of the company’s new facilities—a former magazine plant in ...

Odisha unveils new Pharma Policy with incentives to attract investments, launching two clusters at Pharma Conclave 2025.

The global biotech is promising to create American jobs but has not said where its new plasma therapy manufacturing site will ...

United States President Donald Trump’s planned tariffs on pharmaceuticals have disrupted the industry. Here’s a timeline of ...

Regeneron is expanding its pharmaceutical production in New York, joining a wave of drug companies growing domestic ...

The provisional patent application, titled, “Raphael Pharmaceutical, Inc. / Rambam MedTech Formula for Treating Neutrophil-Dominant Autoimmune Diseases (including RA)” (No. 63/911,729), was filed ...